Orchestra BioMed Holdings Inc. (OBIO) earnings · rev $33.5M
These earnings events as JSON? API free 100/dayOrchestra BioMed Holdings Inc. (OBIO) is a biotechnology company listed on NASDAQ.
This OBIO earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported OBIO revenue for 2025-12-31 was $33.5M. Net income was -$52.7M. Revenue was up 1169.2% from 2024-12-31 to 2025-12-31. OBIO currently screens at market cap $231.7M.
When the next OBIO 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 1169.2% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full OBIO research stays on the stock page; the tape stays on the quote page.
OBIO earnings FAQ
What are OBIO's latest revenue and net income?
Latest cached Orchestra BioMed Holdings Inc. (OBIO) revenue for Dec 31, 2025 was $33.5M. Net income was -$52.7M. Statements: https://lician.com/financials/obio
What is OBIO's latest diluted EPS?
Latest cached Orchestra BioMed Holdings Inc. (OBIO) diluted EPS for Dec 31, 2025 was -$1.11.
What period does the latest OBIO earnings print cover?
The latest cached Orchestra BioMed Holdings Inc. (OBIO) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did OBIO revenue change from the prior cached period?
Cached Orchestra BioMed Holdings Inc. (OBIO) revenue was up 1169.2% from $2.6M (Dec 31, 2024) to $33.5M (Dec 31, 2025). Statements: https://lician.com/financials/obio
Where are OBIO earnings listed?
Cached earnings facts for Orchestra BioMed Holdings Inc. (OBIO) are listed at https://lician.com/earnings/obio. Statements: https://lician.com/financials/obio
Not investment advice.